Literature DB >> 12032026

Oral ketamine: a promising treatment for restless legs syndrome.

Neeraj Kapur1, Robert Friedman.   

Abstract

IMPLICATIONS: Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome. A mechanism for the efficacy of this treatment is discussed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12032026     DOI： 10.1097/00000539-200206000-00034

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  5 in total

1.  Thalamic glutamate/glutamine in restless legs syndrome: increased and related to disturbed sleep.

Authors:  Richard P Allen; Peter B Barker; Alena Horská; Christopher J Earley
Journal:  Neurology       Date:  2013-04-26       Impact factor: 9.910

2.  Anesthetic Management of a Patient With Restless Legs Syndrome: A Case Report.

Authors:  Naohiro Ohshita; Koji Yamagata; Akio Himejima; Kazuhiro Kaneda; Teruyuki Yasutome; Yoshiko Matsuda; Yasuo M Tsutsumi; Yoshihiro Momota
Journal:  Anesth Prog       Date:  2020-12-01

Review 3.  The Importance of Magnesium in Clinical Healthcare.

Authors:  Gerry K Schwalfenberg; Stephen J Genuis
Journal:  Scientifica (Cairo)       Date:  2017-09-28

Review 4.  Restless legs syndrome: Over 50 years of European contribution.

Authors:  Samson G Khachatryan; Raffaele Ferri; Stephany Fulda; Diego Garcia-Borreguero; Mauro Manconi; Maria-Lucia Muntean; Ambra Stefani
Journal:  J Sleep Res       Date:  2022-07-09       Impact factor: 5.296

Review 5.  New Insights into the Neurobiology of Restless Legs Syndrome.

Authors:  Sergi Ferré; Diego García-Borreguero; Richard P Allen; Christopher J Earley
Journal:  Neuroscientist       Date:  2018-07-26       Impact factor: 7.235
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.